Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Cummings

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Diabetes and Its Complications|March 9, 2016
The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trialMarc Atkin, David Laight, Michael H Cummings
British Journal of Clinical Pharmacology|November 18, 2003
Nitrate tolerance and the links with endothelial dysfunction and oxidative stressKatherine E Fayers, Michael H Cummings, Kenneth M Shaw, et al.
BMC Gastroenterology|April 2, 2021
A randomised placebo controlled trial of VSL#3<sup>®</sup> probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver diseasePui Lin Chong, David Laight, Richard J Aspinall, et al.
Pharmacoeconomics|September 19, 2002
UK department of health guidance on prescribing for impotence following the introduction of sildenafil: potential to contain costs in the average health authority districtMartin Ashton-Key, Michael Sadler, Byron Walmsley, et al.
Diabetes & Vascular Disease Research|September 4, 2018
Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring systemRamzi A Ajjan, Michael H Cummings, Peter Jennings, et al.
Diabetes & Vascular Disease Research|February 16, 2018
Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practiceRamzi A Ajjan, Michael H Cummings, Peter Jennings, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 24, 2020
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UKMafalda Ramos, Michael H Cummings, Anastasia Ustyugova, et al.
Diabetes Care|January 2, 2016
Could the Discrepancy in Perceived Emotional Care Received and Provided Be a Barrier to Active Diabetes Self-management? Insights From the Second Diabetes Attitudes, Wishes and Needs (DAWN2) StudyKatharine D Barnard, Richard I G Holt, Pamela A Dyson, et al.
Diabetes Care|March 29, 2002
Postischemic microcirculatory blood flow correlates negatively and independently with plasma C-reactive protein in longstanding type 1 diabetesJames Gibney, Ute Weis, Ben Turner, et al.
Pediatric Pulmonology|July 19, 2022
Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosisAdam J Causer, Janis K Shute, Michael H Cummings, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Diabetes and Its Complications|March 9, 2016
The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trialMarc Atkin, David Laight, Michael H Cummings
British Journal of Clinical Pharmacology|November 18, 2003
Nitrate tolerance and the links with endothelial dysfunction and oxidative stressKatherine E Fayers, Michael H Cummings, Kenneth M Shaw, et al.
BMC Gastroenterology|April 2, 2021
A randomised placebo controlled trial of VSL#3<sup>®</sup> probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver diseasePui Lin Chong, David Laight, Richard J Aspinall, et al.
Pharmacoeconomics|September 19, 2002
UK department of health guidance on prescribing for impotence following the introduction of sildenafil: potential to contain costs in the average health authority districtMartin Ashton-Key, Michael Sadler, Byron Walmsley, et al.
Diabetes & Vascular Disease Research|September 4, 2018
Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring systemRamzi A Ajjan, Michael H Cummings, Peter Jennings, et al.
Diabetes & Vascular Disease Research|February 16, 2018
Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practiceRamzi A Ajjan, Michael H Cummings, Peter Jennings, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 24, 2020
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UKMafalda Ramos, Michael H Cummings, Anastasia Ustyugova, et al.
Diabetes Care|January 2, 2016
Could the Discrepancy in Perceived Emotional Care Received and Provided Be a Barrier to Active Diabetes Self-management? Insights From the Second Diabetes Attitudes, Wishes and Needs (DAWN2) StudyKatharine D Barnard, Richard I G Holt, Pamela A Dyson, et al.
Diabetes Care|March 29, 2002
Postischemic microcirculatory blood flow correlates negatively and independently with plasma C-reactive protein in longstanding type 1 diabetesJames Gibney, Ute Weis, Ben Turner, et al.
Pediatric Pulmonology|July 19, 2022
Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosisAdam J Causer, Janis K Shute, Michael H Cummings, et al.
Pageof 2